Hypodermic Needles Market PPT 2023: Size, Growth, Demand and Forecast till 2028

Author: Elena Anderson, Marketing Manager |

Group

Report DescriptionAbout IMARC Group

The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Global Hypodermic Needles Market Research Report:

The latest report by IMARC, titled “ HypodermicNeedlesMarket:GlobalIndustryTrends,Share,Size,Growth,OpportunityandForecast 2023-2028

” "the global hypodermic needles market reached a valueof US$2.7 Billion in 2022.

Hypodermic needles are sterile, hollow needles that are employed across the medical sector to perform different applications, such as blood specimen collection, drug delivery, and vaccination. They are primarily used with syringes for administering pharmaceutical drugs or extracting blood or other bodily fluids as samplesforexamination orresearch purposes.

Hypodermic needles aid in delivering an accurate amount of drug, enabling users to self-administer, and providing medications that cannot be indigested orally while ensuring optimal safety and convenience. Along with this, hypodermic needles comprise a smooth and sharp surface, which minimizes contamination during the inoculation of the sterile substrate. Currently, they are commercially availablein varying gaugesizes, needlelengths, and diameters.

Request Free Sample Report: https://www.imarcgroup.com/hypodermic-needles-market/requestsample

Global Hypodermic Needles Market Trends:

The widespread adoption of hypodermic needles across the healthcare sector can be attributed to the increasing need for an intravenous vaccine delivery mode for instant intradermal liquid administration during vaccination and sample collection. Additionally, the fueling compliance with safety needles to prevent the risk of needle stick injuries and infection is acting as another growth-inducing factor. In line with this, the outbreak of the COVID-19 pandemic and the escalating health concerns have prompted governments of different nations to promote the uptake of hypodermic safety needles to inhibit the re-utilization of needles, which is positively stimulating the market growth.

Moreover, the advent of ultra-short and thin hypodermic needle pens with improved drug delivery systems that offer reduced pain and discomfort during self-dosage is contributing to the market growth. Furthermore, the escalating number of blood donations across the globe are supplementing the product demand in the market. Other factors, such as substantial expansion in the healthcare infrastructure and strategic collaborations amongst key players to engineer self-dosage hypodermic needles at cost-effective prices, are creating a positive outlook for the market. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 4.1 Billion by 2028, growing at a CAGR of 6.9% during 2023-2028.

Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

Report Description Report Description and Highlights

MarketSummary:

BreakupbyProductType:

• Safety HypodermicNeedles

• Non-Safety HypodermicNeedles

BreakupbyApplication:

• Drug Delivery

• Vaccination

• Blood Specimen Collection

BreakupbyEndUser:

• HospitalsandClinics

• Ambulatory Surgical Centers

• DiabeticPatients

• Family Practices

• Psychiatrics

• Others

Report Description Report Description and Highlights

BreakupbyRegion:

• North America

• United States

• Canada

• Asia-Pacific

• China

• Japan

• India

• South Korea

• Australia

• Indonesia

• Others

• Europe

• Germany

• France

• United Kingdom

• Italy

• Spain

• Russia

• Others

• MiddleEast and Africa

Report Description Report Description and Highlights

CompetitiveLandscapewithKeyPlayers:

• B. Braun Melsungen AG

• Becton Dickinson andCompany

• Cardinal Health Inc.

• Connecticut Hypodermics Inc.

• EXELINT International Co. Hi-Tech Syringes

• McKesson Corporation

• Medline IndustriesLP

• Nipro Corporation

• Retractable TechnologiesInc.

• SmithsMedical Inc. (ICUMedical Inc.)

• Terumo Corporation.

ViewFullReportwithTOC&ListofFigure:

https://www.imarcgroup.com/hypodermic-needles-market

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2019 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.